Breaking News
0

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
178.25 -0.25    -0.14%
11:35:00 - Closed. Currency in EUR ( Disclaimer )
Type: Equity
Market: Germany
ISIN: US0311621009 
WKN: 867900
  • Volume: 672
  • Bid/Ask: 178.08 / 178.43
  • Day's Range: 177.55 - 179.33
Amgen 178.25 -0.25 -0.14%

AMGN Overview

 
Information about the Amgen Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close178.5
Day's Range177.55 - 179.33
RevenueN/A
Open178.15
52 wk Range134.4 - 187.99
EPSN/A
Volume672
Market Cap114.32B
Dividend (Yield)5.10 (2.90%)
Average Vol. (3m)988
P/E RatioN/A
BetaN/A
1-Year Change14.63%
Shares OutstandingN/A
Next Earnings DateJan 29, 2019
What is your sentiment on Amgen Inc?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News


Hospitals squeezed by high drug costs
Hospitals squeezed by high drug costs By Seeking Alpha - Jan 16, 2019

A study funded by the American Hospital Association, Federation of American Hospitals and the American Society of Health-System Pharmacists found that total drug spend per hospital...

FDA to beef up cell and gene therapy staff
FDA to beef up cell and gene therapy staff By Seeking Alpha - Jan 15, 2019

Citing the 800 active INDs for cell therapy and gene therapy candidates and the expectation that it will be receiving more that 200 INDs each year by 2020, FDA Commission Scott...

Amgen Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Sell Sell BUY Strong Buy Strong Buy
Summary Neutral Neutral Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Engulfing Bearish 1M 1 Dec 18
Engulfing Bearish 1M 3 Oct 18
Engulfing Bearish 30 5 Jan 22, 2019 06:00AM
Doji Star Bearish 5H 6 Jan 17, 2019 11:00PM
Tri-Star Bullish 15 6 Jan 22, 2019 07:00AM

Amgen Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 201.98 199.26 201.97 3,173,062 -0.93% USD 15:59:59  
  Mexico 3,821.00 0.00 0.00 0 +0.00% MXN 17/01  
  Switzerland 201.00 0.00 0.00 0 +0.00% CHF 21/01  
  Berlin 177.90 177.64 178.03 0 -0.41% EUR 02:08:00  
  Frankfurt 178.69 0.00 0.00 704 -0.27% EUR 09:39:00  
  Xetra 178.25 178.08 178.43 672 -0.14% EUR 11:35:00  
  TradeGate 177.20 177.73 178.34 227 -1.11% EUR 15:14:00  
  Munich 178.08 0.00 0.00 20 +0.14% EUR 07:03:00  
  Stuttgart 178.15 0.00 0.00 0 -0.22% EUR 00:00:00  
  BM&FBovespa 767.15 0.00 0.00 300 +0.44% BRL 14:12:00  
  Hong Kong 1,000.00 0.00 0.00 0 +0.00% HKD 05/04  
  Vienna 178.730 0.000 0.000 0 -0.16% EUR 21/01  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 153.30 156.73 152.62 -3.52 -2.24% 30.39M 15:59:59  
  Alphabet A 1,078.63 1,098.97 1,070.89 -28.67 -2.59% 1.98M 15:59:59  
  Facebook 147.57 151.53 146.37 -2.47 -1.65% 22.38M 15:59:59  
  X T L Biopharma 2.180 2.410 2.100 +0.190 +9.55% 32.16K 15:59:59  
  Amazon.com 1,632.17 1,681.87 1,610.20 -64.03 -3.77% 6.42M 15:59:59  
  Tesla 298.92 308.00 295.50 -3.34 -1.10% 12.07M 15:59:59  
  Vale ADR 14.450 14.550 14.315 -0.160 -1.10% 28.37M 15:59:59  
  Petroleo Brasileiro Petrobras ADR 15.18 15.46 15.03 -0.22 -1.43% 11.91M 15:59:59  
  Cleveland-Cliffs 8.720 8.880 8.560 -0.290 -3.22% 7.29M 15:59:59  
  Microsoft 105.68 107.10 104.86 -2.03 -1.88% 32.37M 15:59:59  

Amgen Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

20800

Equity Type

ORD

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMGN Comments

Write your thoughts about Amgen
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
anshum gupta
anshum gupta May 16, 2016 3:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibility of a correction from the current levels, but it becomes a good buy in between 144.5-147.5 for the targets of 157.5/159.35/173.3/180. If kept from a longer term perspective, then ultimate target of 210 and above is possible. Keep a stop loss of below 137.5 on a monthly closing basis. Happy investing!!!!
Reply
1 0
Christian Heine
Christian Heine May 16, 2016 3:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The correction should have occured in after trades...speculative attack..
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email